First Policy Makers’ Forum’ Summit

August 21, 2024

Union Minister J.P. Nadda launched two important digital healthcare tools at the First Policy Makers’ Forum in New Delhi: the Indian Pharmacopoeia Online Portal and the Adverse Drug Reaction Monitoring System (ADRMS) software. These initiatives highlight the Indian government’s efforts to digitize healthcare standards and improve the safety of medicines.

Indian Pharmacopoeia Online Portal

The Indian Pharmacopoeia Online Portal is a new digital resource that makes drug standards easier to access for everyone, both in India and worldwide. This portal is part of India’s larger push to go digital, making it simpler for people involved in healthcare to get the information they need.

Adverse Drug Reaction Monitoring System (ADRMS)

The ADRMS is a new tool created in India to help keep track of any problems people might have with medicines and medical devices. It’s the first system of its kind in the country and allows both regular people and healthcare workers to report issues directly. This helps ensure that medicines and medical devices are safe for everyone.

Impacts on Drug Safety

These digital platforms are expected to make it easier and quicker to monitor drug safety. By simplifying the reporting process, they help improve the overall safety of medicines in India. At the forum, policymakers from 15 different countries came together to discuss these new tools. This international participation helps promote India’s leadership in global health and the recognition of the Indian Pharmacopoeia worldwide.

Commitment to Affordable Medicines

India is often called the ‘pharmacy of the world’ because it produces a large number of affordable generic medicines. These medicines are especially important for treating common health issues in developing countries, and this focus on affordability is part of a global trend towards cheaper healthcare. The First Policy Makers’ Forum will continue until August 2024, with ongoing discussions on how to improve drug safety and standards in India’s pharmaceutical sector. The collaboration between different ministries and international experts shows India’s commitment to better global healthcare.

« Previous Post Next Post »